In preclinical stroke studies, SS-31 decreased infarct size, improved functional recovery, and protected neuronal cells via stabilization of mitochondrial membrane, thereby preventing cytochrome c diffusion in stroke pathology. Here, CYCS is linked to stroke disorder.